Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1980 1
1981 1
1989 1
1990 1
1991 1
1992 2
1993 2
1994 2
1997 1
2000 1
2003 1
2005 2
2006 4
2007 2
2008 1
2009 3
2010 1
2011 2
2012 3
2013 3
2016 3
2017 2
2018 4
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Electrolyte disorders and arrhythmogenesis.
El-Sherif N, Turitto G. El-Sherif N, et al. Cardiol J. 2011;18(3):233-45. Cardiol J. 2011. PMID: 21660912 Free article. Review.
Several cardiac and non cardiac drugs are known to suppress the HERG K+ channel and hence the I(K), and especially in the presence of hypokalemia, can result in prolonged action potential duration and QT interval, QTU alternans, early afterdepolarizations, and torsade
Several cardiac and non cardiac drugs are known to suppress the HERG K+ channel and hence the I(K), and especially in the presence of hypoka …
Mineral metabolism and cardiovascular disease in CKD.
Fujii H, Joki N. Fujii H, et al. Clin Exp Nephrol. 2017 Mar;21(Suppl 1):53-63. doi: 10.1007/s10157-016-1363-8. Epub 2017 Jan 6. Clin Exp Nephrol. 2017. PMID: 28062938 Review.
Slow progression of cardiac disorders, such as vascular calcification and cardiac remodeling, characterizes cardiac disease due to CKD-MBD. In contrast, fatal arrhythmia may be induced when QT prolongation occurs with CKD-MBD treatment, such as with lower Ca dialysate or t …
Slow progression of cardiac disorders, such as vascular calcification and cardiac remodeling, characterizes cardiac disease due to CKD-MBD. …
Electrolytes.
Shrimanker I, Bhattarai S. Shrimanker I, et al. 2020 Sep 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 31082167 Free Books & Documents. Review.
Hypercalcemia is when corrected serum total calcium levels exceed 10.7 mg/dl, as seen with primary hyperparathyroidism. Humoral hypercalcemia presents in malignancy, primarily due to PTHrP secretion. ...It can present with alcohol use disorder and gastrointestinal and rena …
Hypercalcemia is when corrected serum total calcium levels exceed 10.7 mg/dl, as seen with primary hyperparathyroidism. Humoral hyper …
Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.
Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, Choi EJ, Chang YS, Bang BK. Kim HW, et al. Nephron Clin Pract. 2006;102(1):c21-9. doi: 10.1159/000088295. Epub 2005 Sep 13. Nephron Clin Pract. 2006. PMID: 16166802
BACKGROUND: Sudden cardiac death is common in patients on hemodialysis (HD), and its rate is as high as 25% of all cardiac deaths associated with left ventricular hypertrophy (LVH) and secondary hyperparathyroidism. A prolonged QT interval on standard electrocardiog …
BACKGROUND: Sudden cardiac death is common in patients on hemodialysis (HD), and its rate is as high as 25% of all cardiac deaths associated …
Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.
Eidman KE, Wetmore JB. Eidman KE, et al. Int J Nephrol Renovasc Dis. 2018 Feb 5;11:69-80. doi: 10.2147/IJNRD.S128252. eCollection 2018. Int J Nephrol Renovasc Dis. 2018. PMID: 29440923 Free PMC article. Review.
Secondary hyperparathyroidism (SHPT) is common in patients receiving maintenance hemodialysis and is associated with adverse outcomes. ...Additionally, etelcalcetide, relative to placebo, causes hypocalcemia and prolonged electrocardiographic QT intervals, effects t …
Secondary hyperparathyroidism (SHPT) is common in patients receiving maintenance hemodialysis and is associated with adverse outcomes …
Multiple Endocrine Neoplasia Type 1.
Giusti F, Marini F, Brandi ML. Giusti F, et al. 2005 Aug 31 [updated 2017 Dec 14]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 20301710 Free Books & Documents. Review.
Biochemical testing detects an increased serum concentration of parathyroid hormone and calcium in primary hyperparathyroidism, increased serum concentrations of prolactin from a prolactinoma, and increased serum concentrations of gastrin, insulin, and VIP from tumors of t …
Biochemical testing detects an increased serum concentration of parathyroid hormone and calcium in primary hyperparathyroidism, incre …
Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.
Ye J, Deng G, Gao F. Ye J, et al. Drug Des Devel Ther. 2018 Apr 19;12:901-909. doi: 10.2147/DDDT.S160223. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29719376 Free PMC article. Review.
Etelcalcetide is the first intravenous calcimimetic agent authorized for the treatment of secondary hyperparathyroidism (sHPT) in patients undergoing hemodialysis in Europe, the US, and Japan. ...In diabetic patients, hypocalcemia may lead to dangerous ventricular arrhythm …
Etelcalcetide is the first intravenous calcimimetic agent authorized for the treatment of secondary hyperparathyroidism (sHPT) in pat …
Treatment of extreme hypercalcaemia: the role of haemodialysis.
Basok AB, Rogachev B, Haviv YS, Vorobiov M. Basok AB, et al. BMJ Case Rep. 2018 Jun 4;2018:bcr2017223772. doi: 10.1136/bcr-2017-223772. BMJ Case Rep. 2018. PMID: 29866671 Free PMC article.
A patient with extremely high calcium level of 23.9 mg/dL (5.97 mmol/L) was admitted to our department unconscious with pathological ECG recording, demonstrating shortening of QT interval. The patient was treated by fluid resuscitation, bisphosphonates, salmon calcitonin a …
A patient with extremely high calcium level of 23.9 mg/dL (5.97 mmol/L) was admitted to our department unconscious with pathological ECG rec …
24-hour outpatient ECG as a screening method in patients with primary hyperparathyroidism.
Dokupilova A, Payer J. Dokupilova A, et al. Bratisl Lek Listy. 2016;117(9):495-500. doi: 10.4149/bll_2016_096. Bratisl Lek Listy. 2016. PMID: 27677191
PURPOSE: Patients with primary hyperparathyroidism are characterized by increased calcium plasma concentrations, which in turn could have a potential to induce ECG changes, especially shortening of the QT interval. ...However, no significant differences were found b …
PURPOSE: Patients with primary hyperparathyroidism are characterized by increased calcium plasma concentrations, which in turn could …
Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease.
Raizada V, Hillerson D, Amaram JS, Skipper B. Raizada V, et al. J Investig Med. 2012 Jun;60(5):785-91. doi: 10.2310/JIM.0b013e318250b101. J Investig Med. 2012. PMID: 22481164 Review.
These cardiac abnormalities are further enhanced by a possible interaction between enhanced RAS activity and hypercalcemia, hyperphosphatemia and secondary hyperparathyroidism, and vitamin D deficiency. The ATII-associated stimulation of aldosterone production from the adr …
These cardiac abnormalities are further enhanced by a possible interaction between enhanced RAS activity and hypercalcemia, hyperphosphatemi …
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback